Latest news for Trident Royalties PLC (OTC:TDTRF) Stock

Trident Royalties PLC

Bernstein analyst Sara Russo maintains ASML Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>) with a Outperform and lowers the price target from $815 to $767.

News

Price Target

Analyst Ratings

ASML

Bernstein Maintains Outperform on ASML Holding, Lowers Price Target to $767

WIIM

PRZO

ParaZero Technologies shares are trading higher after the company announced it received a designation verification report approval from the European Union Aviation Safety Agency for its SafeAir M-300 Pro and SafeAir M-350 Pro parachute safety kits.

DEVS

DevvStream shares are trading higher after the company announced a partnership with Medellin Solar Power to enter the REC market in Asia.

Bernstein analyst William Pickering maintains Arrowhead Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARWR#NASDAQ">ARWR</a>) with a Market Perform and lowers the price target from $27 to $24.

ARWR

Bernstein Maintains Market Perform on Arrowhead Pharma, Lowers Price Target to $24

The earnings results for MINISO Group Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNSO#NYSE">MNSO</a>) for Q1 were made public on Friday, November 29, 2024 at 03:35 AM.
Here's a comprehensive overview of the announcement.
<h3>Earnings</h3>
MINISO Group Holding missed estimated earnings by -6.0%, reporting an EPS of $0.31 versus an estimate of $0.33.
Revenue was up $124.84 million from the same period last year.
<h3>Performance in Previous Earnings</h3>
In the previous quarter, the company missed on EPS by $0.0, resulting in a 1.0% increase change in the share price the following day.
Here's a look at MINISO Group Holding's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.28</td>
<td>0.33</td>
<td>0.27</td>
<td>0.25</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.28</td>
<td>0.27</td>
<td>0.30</td>
<td>0.28</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>566.05M</td>
<td>597.22M</td>
<td>530.30M</td>
<td>504.55M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>555.26M</td>
<td>515.70M</td>
<td>541.04M</td>
<td>519.62M</td>
</tr>
</tbody>
</table>

To track all earnings releases for MINISO Group Holding <a href="https://www.benzinga.com/quote/MNSO/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

MNSO

MINISO Group Holding: Q1 Earnings Insights

BSLK

Bolt Projects shares are trading higher. The company announced a private placement of 1.06 million shares for $360K in gross proceeds.

ALTO

Alto Ingredients Announces That It Will Cold Idle Its Magic Valley, Idaho Facility On December 31, 2024, Yet Continue To Provide Terminal Services At The Plant; Plant Will Operate As A Terminal

Investment to support the growth of the Ondas Autonomous Systems (OAS) business which has experienced substantial demand including $14.4 million in orders in Q3 2024
This represents the third investment in Ondas Holdings convertible notes,with aggregate principal of $50.1 million, since October of 2022 from this single institutional investor
BOSTON, MA / ACCESSWIRE / November 29, 2024 / <a href="https://www.ondas.com/">Ondas Holdings Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONDS#NASDAQ">ONDS</a>) ("Ondas Holdings" or the "Company"), a leading provider of private industrial wireless networks and commercial drone and automated data solutions, announced today that a note holder has elected to purchase $4.1 million in aggregate principal amount of 3% senior convertible notes due 2026 (the "Offering"). Oppenheimer &amp; Co. Inc. will act as placement agent in connection with the Offering. Also, if elected by the note holder, Ondas Holdings may complete additional closings of up to an additional $30.4 million in aggregate principal amount. The proceeds from the investment in Ondas Holdings will be used for general corporate purposes and will be primarily allocated to supporting the growth of our drone business at Ondas Autonomous Systems (OAS).

ONDS

Ondas Announces That A Note Holder Has Elected To Purchase $4.1M In Aggregate Principal Amount Of 3% Senior Convertible Notes Due 2026; Investment To Support The Growth Of The OAS Business Which Has Experienced Substantial Demand Including $14.4M In Orders In Q3 2024

APLT

Applied Therapeutics shares are trading lower after the company announced the FDA highlighted deficiencies in a clinical application for a lead program

In the current session, the stock is trading at $267.30, after a 0.24% increase. Over the past month, Travelers Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRV#NYSE">TRV</a>) stock increased by 8.56%, and in the past year, by 45.56%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2024/1732887007_0.png" alt="Past Year Chart" />

<h3>How Does Travelers Companies P/E Compare to Other Companies?</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of the 18.28 in the Insurance industry, Travelers Companies Inc. has a lower P/E ratio of 13.7. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1732887007_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

Price Over Earnings Overview: Travelers Companies

ParaZero Technologies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRZO#NASDAQ">PRZO</a>) shares are rising on Friday following the company&#8217;s announcement that it received the Design Verification Report (DVR) approval from the<a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g42242189/parazeros-drone-system-received-european-regulatory-approval" rel="noreferrer noopener"> European Union Aviation Safety Agency (EASA).</a>
This approval applies to ParaZero&#8217;s SafeAir M-300 Pro and SafeAir M-350 Pro parachute safety kits, confirming compliance with critical safety standards. The EASA DVR allows drone operators to expand their operational scope under the Specific Operations Risk Assessment (SORA) process.
The SafeAir systems meet the Light-UAS.2511 standard, fulfilling the &#8216;Enhanced Containment&#8217; requirement, which provides robust flight termination capabilities. This offers additional safety for operations in high-risk areas, such as crowded spaces or critical airspaces.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/11/42241785/us-futures-signal-gains-on-the-truncated-trading-day-will-december-witness-a-santa-claus-rally-analysts-decode" rel="noreferrer noopener">US Stocks Likely To Open In The Green To End November On A High: Are Markets Set For A Santa Claus Rally In December? Analysts Decode</a>
Additionally, the SafeAir kits comply with the Light-UAS.2512 standard for impact mitigation, reducing the Ground Risk Class by one point. This reduction grants operators greater flexibility in performing medium-risk missions, such as those beyond visual line of sight or near populated areas.
EASA&#8217;s approval strengthens ParaZero&#8217;s position as a trusted safety solution for drone operations across Europe, ensuring safer and more versatile commercial missions.
Price Action: PRZO shares are trading higher by 40.9% to $0.8999 premarket at last check Friday.
Read Next:
<ul>
<li><a href="http://gop%20megadonor%20ken%20griffin%20slashes%20citadel's%20palantir%20stake%20by%2091%25,%20bets%20big%20on%20nvidia%20as%20jensen%20huang-led%20company%20rises%20over%20180%25%20in%202024/" target="_blank" rel="noreferrer noopener">GOP Megadonor Ken Griffin Slashes Citadel&#8217;s Palantir Stake By 91%, Bets Big On Nvidia As Jensen Huang-Led Company Rises Over 180% In 2024</a></li>
</ul>
Image: Shutterstock/ Dmitry Kalinovsky.

Equities

Movers

General

Why Is Aerospace Company ParaZero Technologies Stock Flying Higher Today?

<h3>Gainers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">51.5100</td>
<td align="right">0.250</td>
<td align="right">0.48</td>
<td>60.9K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">83.2933</td>
<td align="right">0.393</td>
<td align="right">0.47</td>
<td>1.3K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">95.5000</td>
<td align="right">0.380</td>
<td align="right">0.39</td>
<td>5.3K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">220.9200</td>
<td align="right">0.880</td>
<td align="right">0.39</td>
<td>1.4K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">232.2200</td>
<td align="right">0.640</td>
<td align="right">0.27</td>
<td>5.0K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>)</td>
<td>SPDR Select Sector Fund - Industrial</td>
<td align="right">143.5000</td>
<td align="right">0.320</td>
<td align="right">0.22</td>
<td>724</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>)</td>
<td>The Communication Services Select Sector SPDR Fund</td>
<td align="right">98.0700</td>
<td align="right">0.200</td>
<td align="right">0.20</td>
<td>2.0K</td>
</tr>
</tbody>
</table>
No loser in today's Pre-market session. 
<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> this sector movers alerts can help traders understand macro-level market trends. Traders often look for sector movers to provide high-level analysis on which sectors are over- or under-performing to make better investing decisions on exchange traded funds (ETFs) or individual tickers in those sectors. 
To read more about sector movers, <a href="https://www.benzinga.com/movers">click here</a>.

Sector ETFs

Pre-Market Outlook

ETFs

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For November 29, 2024

Prototype development and feasibility testing underway for optimized subcutaneous delivery
SARASOTA, FL, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILO#NASDAQ">SILO</a>) ("Silo" or the "Company"), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today announced a collaboration agreement with Kymanox for specialized design and development of a subcutaneous insertion device for SP-26, the Company's ketamine-loaded implant therapeutic targeting fibromyalgia and chronic pain.
Under terms of the agreement, Kymanox will conduct an initial proof-of-concept design phase followed by full system prototype and feasibility testing to determine optimal insertion depth in tissue.

Biotech

SILO

Silo Pharma Enters Collaboration Agreement With Kymanox For Specialized Design And Development Of A Subcutaneous Insertion Device For SP-26, The Company's Ketamine-Loaded Implant Therapeutic Targeting Fibromyalgia And Chronic Pain

Lithium Americas (Argentina) Corp. ("Lithium Argentina" or the "Company") (TSX:<a href="https://www.benzinga.com/stock/LAAC#TSX">LAAC</a>) (NYSE:<a href="https://www.benzinga.com/stock/LAAC#NYSE">LAAC</a>) today announced its intention to establish corporate domicile in Switzerland under the new name, Lithium Argentina AG. The move, which requires shareholder, stock exchange and court approval, is expected to occur in early 2025.
Lithium Argentina has performed an extensive review of its businesses and corporate structure. Switzerland, was determined to be the best jurisdiction from a strategic, commercial and legal perspective. The move is expected to provide expanded financing flexibility and support the Company's current business and long-term growth plans through access to various markets, proximity to European customers and an attractive framework for existing shareholders and future investment.
The redomiciling of the Company is proposed to be effected by way of plan of arrangement whereby the Company will be continued from the Province of British Columbia, Canada into the jurisdiction of the Canton of Zug, Switzerland. The operational headquarters of the Lithium Argentina group of companies will become Buenos Aires, Argentina.

LAAC

Lithium Americas Intends To Establish Corporate Domicile In Switzerland Under The New Name, Lithium Argentina AG; The Move, Which Requires Shareholder, Stock Exchange And Court Approval, Is Expected To Occur In Early 2025

On Wednesday, the FDA raised concerns about life-threatening hematologic malignancies in patients treated with Bluebird Bio Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLUE#NASDAQ">BLUE</a>) Skysona (elivaldogene autotemcel), a gene therapy for early, active cerebral adrenoleukodystrophy (CALD).
In September 2022, the FDA approved Bluebird Bio&#8217;s&nbsp;Skysona, aka eli-cel, to slow the progression of neurologic dysfunction in boys 4-17 years of age with early, active&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/22/09/28905729/fda-just-okayed-bluebird-bios-3m-gene-therapy-for-rare-neurological-disorder-in-boys-what-investo?_gl=1&#x2A;f5q6x4&#x2A;_gcl_au&#x2A;MzM1NjU4Njk2LjE3MjExMjI2MjY.&#x2A;_ga&#x2A;MTA5NjUzODQ1My4xNzIxMTIyNjI2&#x2A;_ga_V7ZK73W7N0&#x2A;MTcyODYzNTY2NS40MDcuMS4xNzI4NjM2NTAyLjAuMC4w" rel="noreferrer noopener">cerebral adrenoleukodystrophy (CALD</a>).
The agency has received reports of myelodysplastic syndrome and acute myeloid leukemia linked to Skysona, with cases emerging 14 to 92 months post-treatment during clinical trials.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/11/42016766/jp-morgan-downgrades-gene-therapy-focused-bluebird-bio-cites-limited-funding-options" rel="noreferrer noopener">JP Morgan Downgrades Gene Therapy Focused Bluebird Bio, Cites Limited Funding Options</a>
As per new data released in October, seven out of 67 children treated with&nbsp;Bluebird Bio&#8217;s gene therapy for a severe neurological disorder in clinical trials <a target="_blank" href="https://www.benzinga.com/general/biotech/24/10/41290857/worries-mount-over-cancer-risks-in-bluebird-bios-gene-therapy" rel="noreferrer noopener">developed blood cancers</a>.
The FDA is investigating these risks, which include hospitalization, the need for allogeneic hematopoietic stem cell transplantation, and fatal outcomes. Healthcare providers are urged to consider alternative therapies, such as allogeneic stem cell transplants, for patients with suitable, matched donors before opting for Skysona treatment.
Skysona&#8217;s U.S. prescribing information <a target="_blank" href="https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/fda-investigating-serious-risk-hematologic-malignancy-following-skysona-elivaldogene-autotemcel" rel="noreferrer noopener">features</a> a Boxed Warning about the serious risk of hematologic malignancies and additional warnings under the Clinical Trials Experience section.
Patients and clinical trial participants treated with Skysona are advised to undergo lifelong monitoring for malignancies.
To detect potential malignancies early, the FDA recommends regular complete blood counts every three months and assessments for clonal expansion twice within the first year post-treatment.
Annual follow-ups and bone marrow evaluations are also advised as clinically necessary.
In September, Bluebird bio announced it is implementing a restructuring to optimize its cost structure and enable quarterly cash flow break-even in the&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/b40998565/bluebird-bio-initiates-restructuring-intended-to-optimize-cost-structure-and-enable-quarterly-cash" rel="noreferrer noopener">second half of 2025</a>.
The restructuring is expected to result in a 20% reduction in cash operating expenses when fully realized in the third quarter of 2025, compared to the <a target="_blank" href="https://www.benzinga.com/general/biotech/24/09/41008825/gene-therapy-focused-bluebird-bio-restructures-cuts-is-workforce-by-25-seeks-to-breakeven-next-ye" rel="noreferrer noopener">prior reporting period</a>.
Price Action: BLUE stock is up 1.64% at $0.3840 during the premarket session at last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42241802/geopark-seals-530-million-colombian-oil-gas-asset-acquisition-from-repsol" target="_blank" rel="noreferrer noopener">GeoPark Seals $530 Million Colombian Oil &amp; Gas Asset Acquisition Deal With Repsol</a></li>
</ul>
Image via Unsplash

Health Care

BLUE

FDA Probes Potential Life-Threatening Blood Cancer Risks Linked To Bluebird Bio's Skysona Gene Therapy

SOLOWIN HOLDINGS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWIN#NASDAQ">SWIN</a>) ("SOLOWIN" or the "Company"), a leading financial services firm providing high-net-worth and institutional investors with solutions across traditional and virtual assets, today announced its strategic partnership with Horizon Trading Solutions ("Horizon"), a global leader in providing electronic trading solutions and algorithmic technology for capital markets, to integrate Horizon's cutting-edge algorithmic technology and order management system ("OMS") into Solomon JFZ's institutional grade trading system for equities and the recently launched spot virtual asset ETFs.
Horizon's premium Managed &amp; Hosted Services model provides 24/5 follow-the-sun support to ensure clients receive continuous assistance. Having significantly invested in advanced colocation infrastructure, Horizon facilitates rapid order execution on the Hong Kong Stock Exchange and offers real-time latency monitoring. Furthermore, Horizon's customized position management and short selling modules empower high-frequency institutional trading firms to seamlessly submit orders via FIX protocols, significantly enhancing their trading efficiency.
Hong Kong is the world's first market to support innovative in-kind subscription and redemption for spot virtual asset ETFs. Solomon JFZ offers cross-asset market access and premier execution services to institutional investors, as part of its ongoing commitment to bridging traditional (TradFi) and decentralised finance (DeFi). As one of the key participating dealers for virtual asset spot ETFs managed by China Asset Management and Harvest Global Investments, Solomon JFZ has become the largest holder of client assets in various spot virtual asset ETFs in Hong Kong.

SWIN

SOLOWIN Announces Strategic Partnership With Horizon Trading Solutions To Integrate Horizon's Algorithmic Technology And Order Management System Into Solomon JFZ's Institutional Grade Trading System For Equities And The Recently Launched Spot Virtual Asset ETFs

Contango ORE, Inc. ("Contango" or the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTGO#NYSE">CTGO</a>) announced guidance today for its 30% interest in the Peak Gold JV, including reaffirmation of anticipated 2025 gold production and updated anticipated all-in sustaining costs ("AISC") for the mine and 2025 cash distributions from the Peak Gold JV. In addition, the Company provided an update on its credit facility (the "Facility") and related hedge contracts.
The Company anticipates that its share of 2025 gold production from the Manh Choh mine will be approximately 60,000 ounces ("oz") of gold. The estimated AISC for the life-of-mine ("LOM") is projected to increase to approximately $1,400 per oz of gold equivalent ("AuEq") sold compared to $1,116 per oz of AuEq sold, as estimated in the Manh Choh Technical Report Summary1 (the "TRS"), while the estimated AISC for 2025 on a standalone basis is expected to be approximately $1,625 per oz of AuEq sold. A main factor leading to the AISC increase relates to recent weight restrictions on the Chena Flood Plain Bridge, a bridge along the Manh Choh ore haul route, as well as higher than anticipated moisture content in the Manh Choh ore, which limits the overall amount of ore being transported annually by approximately 20% compared to what was originally projected in the TRS. In addition, the AISC is being impacted by higher processing costs. At current hauling rates, the Company expects the LOM to be four to five years. At assumed spot gold prices of $2,500&nbsp;per oz, Contango projects that the 2025 cash distributions from the Peak Gold JV to Contango will be approximately $50 million ("M").

CTGO

Contango Forecasts 2025 Gold Production Of 60K Oz At Manh Choh With Increased AISC At $1,625/Oz; Projects $50M Cash Distribution From Peak Gold JV

Breadth of Global Offering Enables Customization and Business Transformation for Private Credit Funds
OAKS, Pa. and LUXEMBOURG, Nov. 29, 2024 /PRNewswire/ -- <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4313187-1&amp;h=3727240037&amp;u=https%3A%2F%2Fwww.seic.com%2F&amp;a=SEI">SEI</a>&#xAE; (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEIC#NASDAQ">SEIC</a>) today announced that Arrow Global Group Limited (Arrow Global), a leading European alternative asset manager specializing in private credit and real estate, selected SEI to support its fund administration, loan operations, and investor services for its private credit fund domiciled in Luxembourg. Ranked seven out of 129 fund administrators in Luxembourg based on AUA,1 SEI is the largest fund administrator for private market funds in Luxembourg that are managed by a U.S. firm2 and the largest private credit fund administrator by assets globally.3

SEIC

Arrow Global Selects To Support Its Fund Administration, Loan Operations, And Investor Services For Its Private Credit Fund Domiciled In Luxembourg

In the current session, the stock is trading at $22.35, after a 0.49% spike. Over the past month, Healthpeak Properties Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOC#NYSE">DOC</a>) stock increased by 2.58%, and in the past year, by 20.41%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2024/1732885258_0.png" alt="Past Year Chart" />

<h3>Healthpeak Properties P/E Ratio Analysis in Relation to Industry Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of 44.45 in the Helath Care REITs industry, Healthpeak Properties Inc. has a higher P/E ratio of 45.39. Shareholders might be inclined to think that Healthpeak Properties Inc. might perform better than its industry group. It's also possible that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1732885258_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Price Over Earnings Overview: Healthpeak Properties

History shows that higher tariffs have been painful for the stock markets to digest, but President-elect Donald Trump&#8216;s stand on increasing the tariffs seems undeterred, while some <a href="https://www.benzinga.com/news/24/11/42232097/europes-top-central-banker-says-not-to-retaliate-but-to-negotiate-to-avoid-trump-trade-war">analysts call it a negotiating tool,</a> others think that combining it with tax cuts could be good for the economy.
History Of Tariffs
The U.S. has a history of protectionism, with mixed results. The 1930 Smoot-Hawley Tariff Act raised tariffs on many goods with the intention to shield American industries, instead sparked global retaliation and contributed to the deepening of the Great Depression. The Dow Jones Industrial Average plummeted 40% in the year following its passage.
In 1922 Fordney-McCumber Tariff Act aimed to protect American factories and farms. The year was followed by a 10% fall in the Dow Jones.
While Trump also raised tariffs in 2018, it did not deeply affect the market. This is because the 2018 move was a targeted measure and not as broad as what Trump has proposed in his current term.
How Does Higher Tariff Affect The Market?
An <a href="https://www.benzinga.com/24/11/41939162/us-treasuries-edge-up-as-trumps-proposed-policies-possible-rate-cut-may-rekindle-inflation-fears-all-eyes-on-federal-reserves-next-steps">increase in tariffs reduces</a> the demand for imported goods and increases the domestic producer surplus and government tax revenue. However, it also lifts domestic prices above the free trade price, gradually stoking inflation.
Consumers suffer a loss of consumer surplus because of the increase in prices of goods.
However, higher tariffs are <a href="https://www.benzinga.com/markets/24/11/42149533/markets-misread-trump-win-says-ex-goldman-sachs-analyst-prospects-of-tariffs-not-good-for-equities">positive for the domestic currency</a> as its supply decreases and more money flows into the economy.
What Do Analysts Make Of This?
Taking 2015-16 as an example, former Goldman Sachs FX strategist and senior fellow at Brookings Institution, Robin Brooks said in an X post dated Nov. 17 that if the U.S. were to increase the tariffs, China may devalue its currency in response which could lead to monies flowing out of the U.S. economy and into China.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">US tariffs on China are game theory. Prior to tariffs, China will play nice and try to buy off the US. If that doesn&#39;t work, China may devalue hard and fast, causing global market turmoil that spills back to the US and pulls down S&amp;P 500. That&#39;s what happened in 2015 and 2016&#8230; <a href="https://t.co/4GpPSHTWXr">pic.twitter.com/4GpPSHTWXr</a>
&mdash; Robin Brooks (@robin_j_brooks) <a href="https://twitter.com/robin_j_brooks/status/1858200117821497577?ref_src=twsrc%5Etfw">November 17, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Citing a specific example, Brooks, in a post dated Nov. 18 highlighted how the Chinese Yuan fell in 2018 and did not affect inflation in the U.S.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">China tariffs aren&#39;t as inflationary as people think. Take US tariffs on China in 2018. China&#39;s Yuan fell 10% in an almost full offset to US tariffs (25% on half of all imports from China). US import price inflation x/ fuels fell steadily in 2018 because of this FX channel&#8230; <a href="https://t.co/KNkqTttP3k">pic.twitter.com/KNkqTttP3k</a>
&mdash; Robin Brooks (@robin_j_brooks) <a href="https://twitter.com/robin_j_brooks/status/1858568332489658803?ref_src=twsrc%5Etfw">November 18, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
This move by Trump is also being looked at as a negotiating tool to curb unauthorized immigration from Mexico and Canada. But Spencer Hakimian, the founder of Tolou Capital Management said if the policies were to be implemented it may also lead to increased labor costs, aiding to inflation.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">We'll see how much Americans truly hate illegal immigration when they begin to pay American wages for goods and services from all of these industries. Same goes for tariffs. <a href="https://t.co/EQrnbDAuAC">pic.twitter.com/EQrnbDAuAC</a>
&mdash; Spencer Hakimian (@SpencerHakimian) <a href="https://twitter.com/SpencerHakimian/status/1861046157704581462?ref_src=twsrc%5Etfw">November 25, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Also read: <a href="https://www.benzinga.com/24/11/42239447/markets-flopped-in-december-only-once-in-95-years-but-a-bearish-crossover-flagging-market-fall-is-on-the-cards-heres-what-analysts-say">Wall Street&#8217;s December Surprise: What Investors Need to Know Now</a>
As tariffs increase producer surplus by promoting domestic production of goods, tax cuts could additionally aid the companies to allocate more to profitability. &#8220;Tariffs in exchange for tax cuts could have a positive trade-off and it could speed up the innovation,&#8221; said ARK Invest&#8217;s, chief executive officer and chief investment officer, Cathie D Wood in an X post dated Nov. 12.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">How would tariffs on imported goods affect the stock market, particularly in relation to tech stocks? ARK CEO/CIO <a href="https://twitter.com/CathieDWood?ref_src=twsrc%5Etfw">@CathieDWood</a> shares her two cents in <a href="https://twitter.com/hashtag/askARK?src=hash&amp;ref_src=twsrc%5Etfw">#askARK</a>. Do you have more questions for Cathie? Write them below. <a href="https://t.co/gg4EQJAeba">pic.twitter.com/gg4EQJAeba</a>
&mdash; ARK Invest (@ARKInvest) <a href="https://twitter.com/ARKInvest/status/1856371863410078141?ref_src=twsrc%5Etfw">November 12, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Price Action: Markets have been trading higher than their pre-election levels and the expectations of a further 25 basis point rate cut in December rose to just 66%, according to <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">CME Group&#8217;s FedWatch tool.</a> This indicates a further upside in the stock markets.
In premarket trading on Friday, the <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a> showed the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) was up 0.31% to $600.69 and the Invesco QQQ Trust ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NYSE">QQQ</a>) rose 0.44% to $507.50.
The S&amp;P 500 index has risen 26.48% year-to-date to basis. Whereas, the Nasdaq 100, Dow Jones, and Russell 200 Index have returned 25.39%, 18.58%, and 20.54%, respectively. SPY ETF was up by 26.7% and the Invesco ETF advanced by 23.39%, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
<ul>
<li>Read next:  <a href="http://gop%20megadonor%20ken%20griffin%20slashes%20citadel's%20palantir%20stake%20by%2091%25,%20bets%20big%20on%20nvidia%20as%20jensen%20huang-led%20company%20rises%20over%20180%25%20in%202024/" target="_blank" rel="noreferrer noopener">GOP Megadonor Ken Griffin Slashes Citadel's Palantir Stake By 91%, Bets Big On Nvidia As Jensen Huang-Led Company Rises Over 180% In 2024</a></li>
</ul>
Image via Flickr

How Have Markets Reacted To Past US Tariff Hikes? Insights As Trump's Trade Threats Spurs Global Jitters

Trident Royalties (GB:TRR) has released an update. Trident Royalties PLC has announced that Barclays PLC has increased its stake in the company, wi...

Barclays PLC Ups Stake in Trident Royalties

Trident Royalties (GB:TRR) has released an update. Trident Royalties PLC has reported a change in major holdings with Bank of America Corporation c...

Trident Royalties Reports Shift in Major Holdings

Trident Royalties (GB:TRR) has released an update. Bank of America Corporation has adjusted its holdings in Trident Royalties PLC, crossing a notab...

Bank of America Ups Stake in Trident Royalties

Trident Royalties (GB:TRR) has released an update. Trident Royalties PLC has announced that Bank of America Corporation has altered its holdings, r...

Bank of America Adjusts Stake in Trident Royalties

Trident Royalties (GB:TRR) has released an update. Trident Royalties PLC has announced that Bank of America Corporation has changed its stake in th...

Trident Royalties (GB:TRR) has released an update. Trident Royalties PLC has reported that Bank of America Corporation has altered its stake in the...

Trident Royalties (GB:TRR) has released an update. Trident Royalties PLC has announced a change in their major holdings following the acquisition o...

Trident Royalties (GB:TRR) has released an update. Trident Royalties PLC has reported a significant change in ownership, with Bank of America Corpo...

Comments

Trident Royalties PLC

News

Latest news for Trident Royalties PLC (OTC:TDTRF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga